Intrastriatal manganese chloride exposure causes acute locomotor impairment as well as partial activation of substantia nigra GABAergic neurons

Environmental Toxicology and Pharmacology

Volumn 31, Issue 1, 2011, Pages 171-178

  Yang, Yanxia ^a   An, Jiaze ^b   Wang, Yayun ^a   Luo, Wenjing ^a   Wang, Wei ^a   Mei, Xiaopeng ^a   Wu, Shengxi ^a   Chen, Jingyuan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Aminobutyric acid; Dopamine; Locomotor impairment; Manganism; Substantia nigra

Indexed keywords

4 AMINOBUTYRIC ACID; GREEN FLUORESCENT PROTEIN; MANGANESE CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CELL ACTIVATION; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DOPAMINERGIC NERVE CELL; GABAERGIC SYSTEM; IMMUNOFLUORESCENCE TEST; LOCOMOTION; MALE; MOTOR DYSFUNCTION; MOUSE; NEUROTOXICITY; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; ROTAROD TEST; SUBSTANTIA NIGRA;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BEHAVIOR, ANIMAL; CHLORIDES; CORPUS STRIATUM; DOPAMINE; FLUORESCENT ANTIBODY TECHNIQUE; GAIT DISORDERS, NEUROLOGIC; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; GREEN FLUORESCENT PROTEINS; IMMUNOHISTOCHEMISTRY; INJECTIONS; LOCOMOTION; MALE; MANGANESE COMPOUNDS; MANGANESE POISONING; MICE; MOTOR ACTIVITY; NEURONS; POSTURAL BALANCE; SUBSTANTIA NIGRA;

MUS;

EID: 78650226797     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2010.10.004     Document Type: Article

References (35)

1. Aschner M., Erikson K.M., Dorman D.C. Manganese dosimetry: species differences and implications for neurotoxicity. Crit. Rev. Toxicol. 2005, 35:1-32.
2. Ade K.K., Janssen M.J., Ortinski P.I., Vicini S. Differential tonic GABA conductances in striatal medium spiny neurons. J. Neurosci. 2008, 28:1185-1197.
3. Aschner M. Manganese: brain transport and emerging research needs. Environ. Health Perspect. 2000, 108(Suppl. 3):429-432.
4. Beleboni R.O., Carolino R.O., Pizzo A.B., Castellan-Baldan L., Coutinho-Netto J., dos Santos W.F., Coimbra N.C. Pharmacological and biochemical aspects of GABAergic neurotransmission: pathological and neuropsychobiological relationships. Cell. Mol. Neurobiol. 2004, 24:707-728.
5. Bird E.D., Anton A.H., Bullock B. The effect of manganese inhalation on basal ganglia dopamine concentrations in rhesus monkey. Neurotoxicology 1984, 5:59-65.
6. Brouillet E.P., Shinobu L., McGarvey U., Hochberg F., Beal M.F. Manganese injection into the rat striatum produces excitotoxic lesions by impairing energy metabolism. Exp. Neurol. 1993, 120:89-94.
7. Calne D.B., Chu N.S., Huang C.C., Lu C.S., Olanow W. Manganism and idiopathic parkinsonism: similarities and differences. Neurology 1994, 44:1583-1586.
8. Carlsson M., Carlsson A. Interactions between glutamatergic and monoaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease. Trends Neurosci. 1990, 13:272-276.
9. Dietz M.C., Ihrig A., Wrazidlo W., Bader M., Jansen O., Triebig G. Results of magnetic resonance imaging in long-term manganese dioxide-exposed workers. Environ. Res. 2001, 85:37-40.
10. Fegley D.B., Holmes A., Riordan T., Faber C.A., et al. Increased fear- and stress-related anxiety-like behavior in mice lacking tuberoinfundibular peptide of 39 residues. Genes Brain Behav. 2008, 7:933-942.
11. Fitsanakis V.A., Au C., Erikson K.M., Aschner M. The effects of manganese on glutamate, dopamine and gamma-aminobutyric acid regulation. Neurochem. Int. 2006, 48:426-433.
12. Garcia S.J., Gellein K., Syversen T., Aschner M. A manganese-enhanced diet alters brain metals and transporters in the developing rat. Toxicol. Sci. 2006, 92:516-525.
13. Garcia S.J., Gellein K., Syversen T., Aschner M. Iron deficient and manganese supplemented diets alter metals and transporters in the developing rat brain. Toxicol. Sci. 2007, 95:205-214.
14. George P., Keith B.J.F. The Mouse Brain in Stereotaxic Coordinates, Deluxe Second edition 2003.
15. Guilarte T.R., Chen M.K., McGlothan J.L., Verina T., et al. Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates. Exp. Neurol. 2006, 202:381-390.
16. Gwiazda R.H., Lee D., Sheridan J., Smith D.R. Low cumulative manganese exposure affects striatal GABA but not dopamine. Neurotoxicology 2002, 23:69-76.
17. Hemsley K.M., Hopwood J.J. Development of motor deficits in a murine model of mucopolysaccharidosis type IIIA (MPS-IIIA). Behav. Brain Res. 2005, 158:191-199.
18. Ishibashi S., Kuroiwa T., LiYuan S., Katsumata N., Li S., Endo S., Mizusawa H. Long-term cognitive and neuropsychological symptoms after global cerebral ischemia in Mongolian gerbils. Acta Neurochir. 2006, 299-302. (Suppl. 96).
19. Josephs K.A., Ahlskog J.E., Klos K.J., Kumar N., Fealey R.D., Trenerry M.R., Cowl C.T. Neurologic manifestations in welders with pallidal MRI T1 hyperintensity. Neurology 2005, 64:2033-2039.
20. Klos K.J., Chandler M., Kumar N., Ahlskog J.E., Josephs K.A. Neuropsychological profiles of manganese neurotoxicity. Eur. J. Neurol. 2006, 13:1139-1141.
21. Liu X., Sullivan K.A., Madl J.E., Legare M., Tjalkens R.B. Manganese-induced neurotoxicity: the role of astroglial-derived nitric oxide in striatal interneuron degeneration. Toxicol. Sci. 2006, 91:521-531.
22. Mena I., Marin O., Fuenzalida S., Cotzias G.C. Chronic manganese poisoning. Clinical picture and manganese turnover. Neurology 1967, 17:128-136.
23. Nachtman J.P., Tubben R.E., Commissaris R.L. Behavioral effects of chronic manganese administration in rats: locomotor activity studies. Neurobehav. Toxicol. Teratol. 1986, 8:711-715.
24. Luvisetto S., Basso E., Petronilli B.V., Bernardi P., Forte M. Enhancement of anxiety, facilitation of voidance behavior, and occurrence of adult-onset obesity in mice lacking mitochondrial cyclophilin D. Neuroscience 2008, 155:585-596.
25. Sloot W.N., Gramsbergen J.B. Axonal transport of manganese and its relevance to selective neurotoxicity in the rat basal ganglia. Brain Res. 1994, 657:124-132.
26. Struve M.F., McManus B.E., Wong B.A., Dorman D.C. Basal ganglia neurotransmitter concentrations in rhesus monkeys following subchronic manganese sulfate inhalation. Am. J. Ind. Med. 2007, 50:772-778.
27. Takeda A., Kodama Y., Ishiwatari S., Okada S. Manganese transport in the neural circuit of rat CNS. Brain Res. Bull. 1998, 45:149-152.
28. 67-GFP knock-in mouse. J. Comp. Neurol. 2003, 467:60-79.
29. Tapin D., Kennedy G., Lambert J., Zayed J. Bioaccumulation and locomotor effects of manganese sulfate in Sprague-Dawley rats following subchronic (90 days) inhalation exposure. Toxicol. Appl. Pharmacol. 2006, 211:166-174.
30. Tran T.T., Chowanadisai W., Crinella F.M., Chicz-DeMet A., Lonnerdal B. Effect of high dietary manganese intake of neonatal rats on tissue mineral accumulation, striatal dopamine levels, and neurodevelopmental status. Neurotoxicology 2002, 23:635-643.
31. Tran T.T., Chowanadisai W., Lonnerdal B., Le L., Parker M., Chicz-Demet A., Crinella F.M. Effects of neonatal dietary manganese exposure on brain dopamine levels and neurocognitive functions. Neurotoxicology 2002, 23:645-651.
32. Uchino A., Noguchi T., Nomiyama K., Takase Y., Nakazono T., Nojiri J., Kudo S. Manganese accumulation in the brain: MR imaging. Neuroradiology 2007, 49:715-720.
33. Vladimir M.P., Thomas H.L., Katerina V.S. Use of a platform in an automated open-field to enhance assessment of anxiety-like behaviors in mice. J. Neurosci. Methods 2007, 162:222-228.
34. West M., Mhatre M., Ceballos A., et al. The arachidonic acid 5-lipoxygenase inhibitor nordihydroguaiaretic acid inhibits tumor necrosis factor alpha activation of microglia and extends survival of G93A-SOD1 transgenic mice. J. Neurochem. 2004, 91:133-143.
35. Zhao F., Cai T., Liu M., Zheng G., Luo W., Chen J. Manganese induces dopaminergic neurodegeneration via microglial activation in a rat model of manganism. Toxicol. Sci. 2009, 107:156-164.